Research programme: leukotriene A4 hydrolase inhibitors - deCODE geneticsAlternative Names: LTA4H inhibitors - deCODE
Latest Information Update: 16 Jul 2016
At a glance
- Originator deCODE genetics
- Class Ethers; Piperidines; Pyrrolidines
- Mechanism of Action Leukotriene A4 hydrolase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Myocardial infarction; Stroke
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Stroke in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Myocardial-infarction in USA
- 17 Apr 2007 Preclinical trials in Stroke in USA (unspecified route)